15 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

15 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD
Treatment and conditionWhere it standsTrials
15 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD for parkinson diseaseTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1